PetMed CFO says allegations of marketing to opioid addicts are ‘bogus’

SAN FRANCISCO (Reuters) – A short seller’s allegations that PetMed Express markets pet medicine to human opioid addicts are “bogus,” PetMed Chief Financial Officer Bruce Rosenbloom told Reuters on Wednesday.

This post was syndicated from Reuters: Health News. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply